Lab values

aPTT lab values

The activated partial thromboplastin time (aPTT) is the number of seconds plasma takes to clot through the intrinsic and common pathways, including factors XII, XI, IX, VIII, X, V, prothrombin and fibrinogen. It does not test factor VII. The aPTT is the classic test for adjusting an unfractionated heparin infusion. It is also ordered to work up bleeding, and to look for hemophilia or lupus anticoagulant.

Checked against the sources below November 2026

Normal range

TestUS unitsSI unitsNotes
aPTT25–35 seconds25–35 secondsTherapeutic on heparin 1.5–2 times control (label; many texts 1.5–2.5), or anti-Xa per protocol

Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All coagulation values

aPTT in the ICU

Prolonged aPTT

On a heparin infusion the label target is 1.5 to 2 times normal; many texts use 1.5 to 2.5, and many hospitals use an anti-Xa protocol instead. Off heparin, a long aPTT means a factor is low, blocked or consumed.

Causes

Signs and symptoms

Nursing actions

  1. Check the aPTT against the heparin protocol and adjust the infusion only per the protocol and order
  2. Hold or reduce the heparin infusion per protocol when the aPTT is above range, and report it
  3. Assess for bleeding at lines and incisions, and in urine, stool and emesis
  4. Report a fall in hematocrit or blood pressure at once and anticipate a check for hidden bleeding
  5. Anticipate an order for protamine for serious bleeding or overdose, and have resuscitation equipment ready
  6. Monitor the platelet count on heparin and report a large fall
  7. Teach the client to report bleeding gums, black stools and blood in urine

Drawing and reading the sample

On the exam

Check yourself: 3 questions

Question 1 · Coagulation & Hematology

A patient with NSTEMI on a weight-based heparin infusion has a 6-hour aPTT of 118 seconds (target 60–80 seconds). The unit's nomogram includes a 1-hour hold for values above 100 seconds. There is no bleeding, and hemoglobin is stable. Which action is MOST appropriate?

  1. hold 1 hour, then restart at the same rate.
  2. hold 1 hour, then restart at a lower rate.
  3. stop heparin and recheck the aPTT tomorrow.
  4. give protamine to reverse the excess heparin.
Show the answer and rationale

Answer: B

  • A. Tempting because it follows the hold step exactly, but the rate that produced an aPTT of 118 seconds will drive it back above target, so nomograms also lower the rate.
  • B. Correct. For a markedly high aPTT without bleeding, heparin nomograms hold the infusion briefly, restart it at a reduced rate and recheck the aPTT in 6 hours.
  • C. Tempting because it looks cautious, but stopping for a day leaves a patient with active ACS unprotected.
  • D. Tempting because the aPTT is far above target, but protamine is for severe bleeding or urgent surgery; heparin's short half-life lets a hold correct the level.

Unfractionated heparin has a short half-life, so a level well above target falls quickly once the infusion is held. Hospitals titrate with an aPTT nomogram tailored to their reagent; in the ACCP example nomogram, an aPTT above the top band means hold 1 hour, then decrease the infusion by 3 units/kg/hr. The aPTT is rechecked 6 hours after each change and every 6 hours until two consecutive values are therapeutic, then daily. The nurse also checks for bleeding, the pump settings and the dosing weight. Protamine is kept for severe bleeding or surgery.

Sources: StatPearls (NCBI Bookshelf); ACCP Antithrombotic Guidelines 9th ed: Parenteral Anticoagulants (2012)

Question 2 · Coagulation & Hematology

A patient receiving IV unfractionated heparin for pulmonary embolism has needed more than 35,000 units/day for 48 hours without reaching the target aPTT. Platelets are stable at 240,000/mm³. Antithrombin activity is 42% (low). Which explanation is MOST likely?

  1. A lupus anticoagulant falsely shortening the aPTT
  2. Vitamin K deficiency limiting the heparin response
  3. Antithrombin deficiency, which heparin needs to work
  4. Heparin-induced thrombocytopenia causing drug resistance
Show the answer and rationale

Answer: C

  • A. A lupus anticoagulant prolongs the baseline aPTT rather than shortening it.
  • B. Vitamin K affects warfarin and clotting factor synthesis, not heparin’s mechanism.
  • C. Correct. Heparin works by enhancing antithrombin, so low antithrombin blunts its effect.
  • D. HIT causes a falling platelet count and thrombosis. It does not cause heparin resistance with stable platelets.

Unfractionated heparin binds antithrombin and speeds its inactivation of thrombin (IIa) and factor Xa by about 1,000-fold. Heparin resistance can result from antithrombin deficiency (congenital, consumption, or from prior heparin use), high levels of factor VIII or fibrinogen (acute phase reactants), or increased heparin clearance. Options include monitoring by anti-Xa level rather than aPTT, antithrombin supplementation, or switching to a direct thrombin inhibitor.

Sources: Elsevier's 2025 Intravenous Medications; Mosby's Diagnostic & Lab Reference, 15th ed.; AACN Core Curriculum, 8th ed.

Question 3 · ECMO Fundamentals & Troubleshooting

On day 3 of VA-ECMO on heparin, a patient has aPTT 96 seconds (target 60–80) and anti-Xa 0.22 IU/mL (target 0.3–0.7). INR is 2.1 from hepatic congestion; plasma free hemoglobin and bilirubin are normal. Which interpretation is MOST accurate?

  1. both results confirm the dose is adequate.
  2. the anti-Xa better reflects heparin effect.
  3. heparin is supratherapeutic and should be held.
  4. the anti-Xa is falsely low from hemolysis.
Show the answer and rationale

Answer: B

  • A. Neither value sits in its target range, and they point in opposite directions, so the dose cannot be called adequate.
  • B. Correct. The aPTT is prolonged by the factor deficit behind the INR of 2.1, while the anti-Xa measures heparin activity, which is below target.
  • C. Reading the long aPTT alone suggests too much heparin, but liver-related factor deficiency lengthens the aPTT without more heparin effect.
  • D. Hemolysis and high bilirubin can falsely lower chromogenic anti-Xa results, but both are normal here, so the result can be trusted.

The aPTT measures the whole intrinsic clotting pathway, so liver disease, vitamin K deficiency or warfarin, lupus anticoagulant and hemolysis can prolong it without any change in heparin effect. The anti-Xa assay measures heparin's functional inhibition of factor Xa and is less affected by those conditions, although its chromogenic method can read falsely low with hemolysis, hyperbilirubinemia or high triglycerides. In mechanical circulatory support, aPTT and anti-Xa disagree in most paired samples, usually with the aPTT higher. With interference excluded, the anti-Xa of 0.22 IU/mL shows subtherapeutic heparin; ELSO's 2021 guideline uses a 0.3 to 0.7 IU/mL anti-Xa range, so the nurse reports for protocol titration.

Sources: StatPearls (NCBI Bookshelf); Li et al., aPTT vs Anti-Xa Discordance in MCS (2024); Ezetendu et al., Hemolysis and Anti-Xa on ECMO, J Extra Corpor Technol (2019)

Practice this in the app

ICU Basics has 38 questions on bleeding, reversal, hit and dic, each with a rationale for every choice. No ads. Pro is coming in January 2027.

Practice in your browser

Download on theApp StoreGet it onGoogle Play

Study the topic

Other lab values

Sources

  1. Merck Manual Professional Edition. Excessive Bleeding (laboratory tests of hemostasis). 2025.
  2. Merck Manual Professional Edition. Overview of Coagulation Disorders. 2025.
  3. DailyMed. Heparin sodium injection, label (Sagent Pharmaceuticals; Henry Schein repackaged). National Library of Medicine.
  4. DailyMed. Argatroban in sodium chloride injection, label (Accord Healthcare), revised 5/2026. National Library of Medicine.
  5. Arachchillage DJ, Kitchen S. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice. Semin Thromb Hemost. 2024;50(8):1153-1162.
  6. Warkentin TE. Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review. Res Pract Thromb Haemost. 2023;7(8):102245.
  7. Shah A, Dohner J, Cheng K, Garcia M, Kost GJ. Visualization of Critical Limits and Critical Values Facilitates Interpretation. Diagnostics (Basel). 2025;15(5):604.
  8. Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline

For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.